1038828-20-4

Basic information

• Product Name: Imidazo[1,2-a]pyridine-2-carboxylic acid, 3-methyl-, ethyl ester
• CAS NO: 1038828-20-4
• Mol File: 1038828-20-4.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: Imidazo[1,2-a]pyridine-2-carboxylic acid, 3-methyl-, ethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Imidazo[1,2-a]pyridine-2-carboxylic acid, 3-methyl-, ethyl ester(1038828-20-4)
• EPA Substance Registry System: Imidazo[1,2-a]pyridine-2-carboxylic acid, 3-methyl-, ethyl ester(1038828-20-4)

Safety Data

• Hazardous Substances Data: 1038828-20-4(Hazardous Substances Data)

Upstream product

• 504-29-0 2-aminopyridine 
• 57332-84-0 3-bromo-2-oxo-butyric acid ethyl ester 
• 15933-07-0 Ethyl 2-oxobutanoate 
• 64-17-5 ethanol 
• 34329-73-2 methyl 3-bromo-2-oxobutanoate 
• 52194-41-9 (Z)-ethyl 3-nitrobut-2-enoate 

Downstream Products

• 1227268-77-0 3-methylimidazo[1,2-a]pyridine-2-carboxylic acid 
• 1381785-35-8 Methyl 4-(N-(3-methylimidazo[1,2-a]pyridin-2-yl)sulfamoyl)benzoate 
• 1381785-34-7 methyl 4-(N-(tert-butoxycarbonyl)-N-(3-methylimidazo[1,2-a]pyridin-2-yl)sulfamoyl)benzoate 
• 1381785-36-9 methyl 4-(N-(3-methylimidazo[1,2-a]pyridin-2-yl)-N-((4-trifluoromethoxy)benzyl)sulfamoyl)benzoate 
• 1381785-18-7 sodium 4-(N-(3-methylimidazo[1,2-a]pyridin-2-yl)-N-((4-trifluoromethoxy)benzyl)sulfamoyl)benzoate 

Relevant articles and documents

Inexpensive Radical Methylation and Related Alkylations of Heteroarenes

A simple method for the introduction of a methyl and higher aliphatic group to various heteroarenes using very inexpensive reagents is described. It is based on the radical addition of a carboxylic xanthate followed by decarboxylation. Depending on the heteroarene structure, the decarboxylation can be spontaneous or induced by heating in N,N-dimethylacetamide or N-methyl pyrrolidone in a microwave oven.

IMIDAZO[1,2-a]PYRIDINE SULFONAMIDES AS TRPM8 MODULATORS

Disclosed are compounds, compositions and methods for treating various diseases, syndromes, conditions and disorders, including pain. Such compounds are represented by Formula I as follows: wherein Y, R1, R2, and are defined herein.